StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BioLargo's shares outstanding was 321M at Jun 30, 2026. For fiscal 2025 it was 307M, up 3.0% from the year before. Over ten years it grew 13.8% a year on average. The highest annual figure on record is 307M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025307M+3.0%
FY2024Dec 31, 2024298M+4.3%
FY2023Dec 31, 2023286M+6.6%
FY2022Dec 31, 2022268M+8.5%
FY2021Dec 31, 2021247M+26.1%
FY2020Dec 31, 2020196M+28.9%
FY2019Dec 31, 2019152M+24.7%
FY2018Dec 31, 2018122M+23.3%
FY2017Dec 31, 201799M+12.5%
FY2016Dec 31, 201688M+4.5%
FY2015Dec 31, 201584M+5.1%
FY2014Dec 31, 201480M+9.7%
FY2013Dec 31, 201373M+14.4%
FY2012Dec 31, 201264M+14.4%
FY2011Dec 31, 201156M+21.6%
FY2010Dec 31, 201046M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026321M+5.9%
Q1 FY2026Mar 31, 2026319M+5.8%
Q4 FY2025Dec 31, 2025314M+4.3%
Q3 FY2025Sep 30, 2025309M+2.8%
Q2 FY2025Jun 30, 2025303M+2.3%
Q1 FY2025Mar 31, 2025301M+2.4%
Q4 FY2024Dec 31, 2024301M+3.8%
Q3 FY2024Sep 30, 2024300M+4.4%
Q2 FY2024Jun 30, 2024296M+4.0%
Q1 FY2024Mar 31, 2024294M+4.8%
Q4 FY2023Dec 31, 2023290M+5.2%
Q3 FY2023Sep 30, 2023288M+6.4%
Q2 FY2023Jun 30, 2023285M+7.2%
Q1 FY2023Mar 31, 2023281M+7.6%
Q4 FY2022Dec 31, 2022276M+6.8%
Q3 FY2022Sep 30, 2022271M+7.0%
Q2 FY2022Jun 30, 2022266M+9.1%
Q1 FY2022Mar 31, 2022261M+11.6%
Q4 FY2021Dec 31, 2021258M+9.8%
Q3 FY2021Sep 30, 2021253M+20.3%
Q2 FY2021Jun 30, 2021244M+34.2%
Q1 FY2021Mar 31, 2021234M+38.4%
Q4 FY2020Dec 31, 2020235M+43.7%
Q3 FY2020Sep 30, 2020210M+34.4%
Q2 FY2020Jun 30, 2020182M+24.6%
Q1 FY2020Mar 31, 2020169M+18.7%
Q4 FY2019Dec 31, 2019164M+22.3%
Q3 FY2019Sep 30, 2019156M+19.9%
Q2 FY2019Jun 30, 2019146M+22.7%
Q1 FY2019Mar 31, 2019142M+35.9%
Q4 FY2018Dec 31, 2018134M+30.3%
Q3 FY2018Sep 30, 2018130M+29.5%
Q2 FY2018Jun 30, 2018119M+21.5%
Q1 FY2018Mar 31, 2018105M+10.9%
Q4 FY2017Dec 31, 2017103M+12.5%
Q3 FY2017Sep 30, 2017101M+14.3%
Q2 FY2017Jun 30, 201798M–
Q1 FY2017Mar 31, 201794M–
Q4 FY2016Dec 31, 201691M–
Q3 FY2016Sep 30, 201688M–

More BioLargo figures

See a number that looks wrong?